Publication Cover
Nutritional Neuroscience
An International Journal on Nutrition, Diet and Nervous System
Volume 4, 2001 - Issue 6
33
Views
24
CrossRef citations to date
0
Altmetric
Reviews

Lipoic Acid Confers Protection Against Oxidative Injury in Non-neuronal and Neuronal Tissue

Pages 419-438 | Received 27 Jun 2001, Published online: 13 Jul 2016

References

  • Altavilla, D., Deodato, B., Campo, G.M., Arlotta, M., Miano, M., Squadrito, G., Saitta, A., Cucinotta, D., Ceccarelli, S., Ferlito, M., Tringali, M., Minutoli, L., Caputi, A.P. and Squadrito, F. (2000) “IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappaB and reduces the inflammatory response in myocardial ischemia-reperfusion injury”, Cardiovasc. Res. 47, 515–528.
  • Alvarez, S. and Boveris, A. (2000) “Antioxidant adaptive response of human mononuclear cells to UV-B: effect of lipoic acid”, J. Pholochem. Photobiol. 55, 113–119.
  • Ames, B.N. (1998) “Micronutrients prevent cancer and delay aging”, Toxicol. Lett. 102–103, 5–18.
  • Androne, L., Gavan, N.A., Veresiu, I.A. and Orasan, R. (2000) “In vivo effect of lipoic acid on lipid peroxidation in patients with diabetic neuropathy”, In Vivo 14, 327–330.
  • Anuradha, B. and Varalakshmi, P. (1999a) “Activities of glucose-metabolizing enzymes in experimental neurotoxic models with lipoate as an alleviator”, J. Appl. Toxicol. 19, 405–409.
  • Anuradha, B. and Varalaksmi, P. (1999b) “Protective role of DL-alpha-lipoic acid against mercury induced neural lipid peroxidation”, Pharmacol. Res. 39, 67–80.
  • Arivazhagan, P. and Panneerselvam, C. (2000a) “Effect of DL-alpha-lipoic acid on tissue nucleic acid contents in aged rats”, Pharmacol Res. 42, 223–226.
  • Arivazhagan, P. and Panneerselvam, C. (2000b) “Effect of DL-α-lipoic acid on neural antioxidants in aged rats”, Pharmacol. Res. 42, 219–222.
  • Arivazhagan, P, Thilakavathy, T. and Panneerselvam, C. (2000a) “Antioxidant lipoate and tissue antioxidants in aged rats”, J. Nutr. Biochem. 11, 122–127.
  • Arivazhagan, P, Juliet, P. and Panneerselvam, C. (2000b) “Effect of DL-α-lipoic acid on the status of lipid peroxidation and antioxidants in aged rats”, Pharmacol. Res. 41, 299–303.
  • Arivazhagan, R, Ramanathan, K. and Panneerselvam, C. (2001) “Effect of DL-alpha-lipoic acid on the status of lipid peroxidation and antioxidants in mitochondria of aged rats”, J. Nutr. Biochem. 12, 2–6.
  • Barbiroli, B., Medori, R., Tritschler, H.J., Klopstock, T., Seibel, P., Reichmann, H., Iotti, S., Lodi, R. and Zaniol, P. (1995) “Lipoic (thioctic) acid increases brain energy availability and skeletal muscle performance as shown by in vivo 31P-MRS in a patient with mitochondrial cytopathy”, J. Neurol. 242, 472–477.
  • Bast, A. and Haenen, G.R. (1988) “Interplay between lipoic acid and GSH in the protection against microsomal lipid peroxidation”, Biochim. Biophys. Acta 963, 558–561.
  • Beckman, K.B. and Ames, B.N. (1998a) “Mitochondrial aging: open questions”, Ann. N.Y. Acad. Sci. 584, 118–127.
  • Beckman, K.B. and Ames, B.N. (1998b) “The free radical theory of aging matures”, Physiol. Rev. 78, 547–581.
  • Benkovic, S.A. and Connor, J.R. (1993) “Ferritin, transferrin and iron in selected regions of the adult and aged rat brain”, J. Comp. Neurol. 338, 97–113.
  • Benveniste, H., Drejer, J., Schousboe, A. and Diemer, N.H. (1984) “Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral myicrodialysis”, J. Neurochem. 43, 1369–1374.
  • Bierhaus, A., Chevion, S., Chevion, M., Hofmann, M., Quehenberger, P., Illmerl, T., Luther, T., Berentshtein, E., Trirschler, H., Muller, M., Wahl, P., Ziegler, R. and Nawroth, P.P. (1997) “Advanced glycation end product-induced activation of NF-kappa B is suppressed by alpha-lipoic acid in cultured endothelial cells”, Diabetes 46, 1482–1490.
  • Biessels, G.J., Kamal, A., Ramakers, G.M., Urban, I.J., Spruijt, B.M., Erkelens, D.W. and Gispen, W.H. (1996) “Place learning and hippocampal synaptic plasticity in streptozotocin induced diabetic rats”, Diabetes 45, 1259–1266.
  • Biessels, G.J., Kamal, A., Urban, I.J., Spruijt, B.M., Erkelens, D.W. and Gispen, W.H. (1998) “Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment”, Brain Res. 800, 125–135.
  • Biessels, G.J., Smale, S., Duis, S.E.J., Kamal, A. and Gtispen, W.H. (2001) “The effect of gamma-linolenic acid-alpha-lipoic acid on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats”, J. Neurol. Sci. 182, 99–106.
  • Biewenga, G.P., Haenen, G.R. and Bast, A. (1997) “The pharmacology of the antioxidant lipoic acid”, Gen. Pharmacol. 29, 315–331.
  • Bliss, T.V.P. and Collingridge, G.L. (1993) “A synaptic model of memory: long-term potentiation in the hippocampus”, Nature 361, 31–39.
  • Bondy, S.C. and LeBel, C.P. (1993) “The relationship between excitotoxicity and oxidative stress in the central nervous system”, Free Radical Biol. Med. 14, 633–642.
  • Borlongan, C.V., Kanning, K., Poulos, S.G., Freeman, T.B., Cahill, D.W. and Sanberg, P.R. (1996) “Free radical damage and oxidative stress in Huntington's disease”, J. Fla. Med. Assoc. 83, 335–341.
  • Bravenboer, B., Kappelle, A.C., Hamers, F.P.T., vanBuren, T., Erkelens, D.W. and Gispen, W.H. (1992) “Potential use of GSH for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat”, Diabetologia 35, 813–817.
  • Bustamante, J., Slater, A.F. and Orrenius, S. (1995) “Antioxidant inhibition of thymocyte apoptosis by dihydrolipoic acid”, Free Radical Biol. Med. 19, 339–347.
  • Cadet, J.L. and Brannock, C. (1998) “Free radicals and the pathobiology of brain dopamine systems”, Neurochem. Int. 32, 117–131.
  • Cameron, N.E., Cotter, M.A. and Maxfield, E.K. (1993) “Antioxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats”, Diabetologia 36, 299–304.
  • Cameron, N.E., Cotter, M.A., Archibald, V., Dines, K.C. and Maxfield, E.K. (1994) “Antioxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in nondiabetic and streptozotocin-diabetic rats”, Diabetologia 37, 449–459.
  • Cameron, N.E., Cotter, M.A., Horrobin, D.F. and Tritschler, H.J. (1998) “Effects of α-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids”, Diabetologia 41, 390–399.
  • Cao, X. and Phillis, J.W. (1995) “The free radical scavenger, alpha lipoic acid, protects against cerebral ischemia-reperfusion injury in gerbils”, Free Radical Res. 23, 265–279.
  • Chiueh, C.C., Huang, S.J. and Murphy, D.I. (1994) “Suppression of hydroxyl radical formation by MAO inhibitors: a novel possible neuroprotective mechanism in MPTP neurotoxicity”, J. Neurol. Transm. Suppl. 41, 189–196.
  • Choi, J.H. and Yu, B.P. (1995) “Brain synaptosomal aging: free radicals and membrane fluidity”, Free Radical Biol. Med. 18, 133–139.
  • Conlon, B.J. and Smith, D.W. (2000) “Topical aminoglycoside ototoxicity: attempting to protect the cochlea”, Acta Otolaryngol. 120, 596–599.
  • Constantinescu, A., Pick, U., Handelmen, G.J., Haramaki, N., Han, D., Podda, M., Tritschler, H.J. and Packer, L. (1995) “Reduction and transport of lipoic acid by human erythrocytes”, Biochem. Pharmacol. 50, 253–261.
  • Darley-Usmar, V., Wisemen, H. and Halliwell, B. (1995) “Nitric oxide and oxygen radicals: a question of balance”, FEBS Lett. 369, 131–135.
  • Dimpfel, W., Spuler, M., Pierau, F.-K. and Ulrick, H. (1990) “Thioctic acid induces dose-dependent sprouting of neuritis in cultured rat neuroblastoma cells”, Dev. Pharmacol. Ther. 14, 193–199.
  • Dykens, J.A. (1994) “Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated Ca2+ and Na+: implications for neurodegeneration”, J. Neurochem. 63, 584–591.
  • Freisleben, H.J. (2000) “Lipoic acid reduces ischemia-reperfusion injury in animal models”, Toxicology 148, 159–171.
  • Garthwaite, J. and Bouton, C.L. (1995) “Nitric oxide signalling in the central nervous system”, Ann. Rev. Physiol. 57, 683–706.
  • Girotti, A.W., Thomas, J.P. and Jordan, J.E. (1985) “Prooxiddant and antioxidant effects of ascorbate on photosensitized peroxidation of lipids in erythrocyte membranes”, Photochem. Photobiol. 41, 267–276.
  • Good, P.F., Perl, D.P., Bierer, L.M. and Schmeidler, J. (1992) “Selective accumulation of aluminium and iron in the neurofibrillary tangles of Alzheimer's Disease: a laser microprobe (LAMMA) study”, Ann. Neurol. 31, 286–292.
  • Good, P.F., Hsu, A., Werner, P., Perl, D.P. and Olanow, C.W. (1998) “Protein nitration in Parkinson's disease”, J. Neuropathol. Exp. Neurol. 57, 338–342.
  • Gotz, M.E., Dirr, A., Burger, R., Janetzky, B., Weinmuller, M., Chan, W.W., Chen, S.C., Reichmann, H., Rausch, W.D. and Riederer, P. (1994) “Effect of lipoic acid on redox state of coenzyme Q in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and diethyldithiocarbamate”, Eur. J. Pharmacol. 266, 291–300.
  • Greenamyre, J.T., Garcia-Osuna, M. and Greene, J.G. (1994) “The endogenous cofactors, thioctic acid and dihydrolipoic acid, are neuroprotective against NMDA and malonic acid lesions of striatum”, Neurosci. Lett. 171, 17–20.
  • Gross, S.S. and Wolin, M.S. (1995) “Nitric oxide: pathophysiological mechanisms”, Ann. Rev. Physiol. 57, 737–769.
  • Guo, Q., Tirosh, O. and Packer, L. (2001) “Inhibitory effect of α-lipoic acid and its positively charged amide analogue on nitric oxide production in RAW 264.7 macrophages”, Biochem. Pharmacol. 61, 547–554.
  • Gurer, H., Ozgunes, H., Oztezcan, S. and Ercal, N. (1999) “Antioxidant role of alpha-lipoic acid in lead toxicity”, Free Radical Biol. Med. 27, 75–81.
  • Hagen, T.M., Yowe, D.L., Bartholomew, J.C., Wehr, C.M., Do, K.L., Park, J.-Y. and Ames, B.N. (1997) “Mitochondrial decay in hepatocytes from old rats: membrane potential declines, heterogeneity and oxidants increase”, Proc. Natl Acad. Sci. 94, 3064–3069.
  • Halliwell, B. (1992) “ROS and the central nervous system”, J. Neurochem. 59, 1609–1623.
  • Han, D., Handelman, G., Marcocci, L., Sen, C.K., Roy, S., Kobuchi, H., Tritschler, H.J., Flohe, L. and Packer, L. (1997a) “Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization”, Biofactors 6, 321–338.
  • Han, D., Sen, C.K., Roy, S., Kobuchi, H., Tritschler, H.J. and Packer, L. (1997b) “Protection against glutamate-induced cytotoxicity in C6 glail cells by thiol antioxidants”, Am. J. Physiol. 273, R1771–R1778.
  • Haramaki, N., Han, D., Handelman, G.J., Tritschler, H.J. and Packer, L. (1997) “Cytosolic and mitochondrial systems for NADH- and NADPH-dependent reduction of alpha-lipoic acid”, Free Radical Biol. Med. 22, 535–542.
  • Haugaard, N. and Haugaard, E.S. (1970) “Stimulation of glucose utilization by thioctic acid in rat diaphragm incubated in vitro”, Biochim. Biophys. Acta 222, 583–586.
  • Ho, E. and Bray, T.M. (1999) “Antioxidants, NFκB activation and diabetogenesis”, Proc. Soc. Exp. Biol. Med. 222, 205–213.
  • Ho, E., Chen, G. and Bray, T.M. (1999) “Supplementation of N-acetylcysteine inhibits NFκB activation and protects against alloxan-induced diabetes in CD-1 mice”, FASEB J. 13, 1845–1854.
  • Hofmann, M., Mainka, P, Tritschler, H., Fuchs, J. and Zimmer, G. (1995) “Decrease of red cell membrane fluidity and—SH groups are due to hyperglycaemic conditions is counteracted by α-lipoic acid”, Arch. Biochem. Biophys. 324, 85–92.
  • Hounsom, L., Horrobin, D.F., Tritschler, H., Corder, R. and Tomlinson, D.R. (1998) “A lipoic acid-gamma-linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy”, Diabetologia 41, 839–843.
  • Jenner, J.P., Daniel, S.E., Lees, A.J., Marsden, D.C. and Halliwell, B. (1998) “Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving ROS”, J. Neurochem. 71, 2112–2122.
  • Joseph, J.A., Shukitt-Halel, B., Denisoval, N.A., Prior, R.L., Caol, G., Martin, A., Taglialatela, G. and Bickford, P.C. (1998) “Long-term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal-transduction and cognitive behavioral deficits”, J. Neurosci. 18, 8047–8055.
  • Kabuto, H., Yokoi, I. and Ogawa, N. (1998) “Melatonin inhibits iron-induced epileptic discharges in rats by suppressing peroxidation”, Epilepsia 39, 237–243.
  • Kagan, V.E., Shvedova, A., Serbinova, E., Khan, S., Swanson, C., Powell, R. and Packer, L. (1992) “Dihydrohpoic acid—a universal antioxidant both in the membrane and in the aqueous phase. Reduction of peroxyl, ascorbyl and chromanoxyl radicals”, Biochem. Pharmacol. 44, 1637–1649.
  • Kamat, J.P. and Devasagayam, T.P. (1996) “Methylene blue plus light-induced lipid peroxidation in rat liver microsomes: inhibition by nicotinamide (vitamin B3) and other antioxidants”, Chem. Biol. Interact. 99, 1–16.
  • Karasu, C., Dewhurst, M., Stevens, E.J. and Tomlinson, D.R. (1995) “Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats: comparison with essential fatty acids”, Diabetologia 38, 129–134.
  • Kaur, H. and Halliwell, B. (1994) “Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients”, FEBS Lett. 350, 9–12.
  • Keller, J.N. and Mattson, M.P. (1998) “Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system”, Rev. Neurosci. 9, 105–116.
  • Khamaisi, M., Potashnik, R., Tirosh, A., Demshchak, E., Rudich, A., Tritschler, H., Wessel, K. and Bashan, N. (1997) “Lipoic acid reduces glycemia and increases muscle GLUT4 content m streptozotocin-diabetic rats”, Metabolism 46, 763–768.
  • Kilic, F., Handelmen, G.J., Serbinova, E., Packer, L. and Trevithick, J.R. (1995) “Modelling cortical cataractogenesis 17: in vitro effect of α-lipoic acid on glucose-induced lens membrane damage, a model for diabetic cataractogenesis”, Biochem. Mol. Biol. Int. 37, 361–370.
  • Lavrovsky, L., Song, C.S., Chatterjee, B. and Roy, A.K. (2000) “Age-dependent increase of heme oxygenase-I gene expression in the liver mediated by NFκB”, Mech. Ageing Dev. 114, 49–60.
  • Lei, S., Pan, Z.-H., Aggarwal, S.K., Chen, H.-S., Hartman, J., Sucher, N.J. and Lipton, S.A. (1992) “Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex”, Neuron 8, 1087–1099.
  • Low, P.A. and Nicklander, K.K. (1991) “Oxygen free radical effects in sciatic nerve in experimental diabetes”, Diabetes 40, 873–877.
  • Lykkesfekdt, J., Hagen, T.M., Vinarsky, V. and Ames, B.N. (1998) “Age-associated decline in ascorbic acid concentration, recycling, and biosynthesis in rat hepatocytes—reversal with (R)-α-lipoic acid supplementation”, FASEB J. 12, 1183–1189.
  • Lynch, M.A. (1998a) “Age-related impairment in long-term potentiation in hippocampus: a role for the cytokine, interleukin-1β?”, Prog. Neurobiol. 56, 571–589.
  • Lynch, M.A. (1998b) “Analysis of the mechanisms underlying the age-related impairment in long-term potentiation in the rat”, Rev Neurosci. 9, 169–201.
  • Mahle, C. and Dasgupta, A. (1997) “Decreased total antioxidant capacity and elevated lipid hydroperoxide concentrations in sera of epileptic patients receiving phenytoin”, Life Sci. 61, 437–443.
  • Maitra, I., Serbinova, E., Tritschler, H.L. and Packer, L. (1996) “Stereospecific effects of R-lipoic acid on buthionine sulfoximine-induced cataract formation in newborn rats”, Biochem. Biophys. Res. Commun. 221, 422–429.
  • Martin, D.S.D., Towey, M., Horrobin, D.F. and Lynch, M.A. (2000) “A diet enriched in α-lipoic acid reverses the age-related compromise in antioxidant defences in rat cortical tissue”, Nut. Neurosci. 3, 193–206.
  • Martinez-Blasco, A., Bosch-Morell, F., Trenor, C. and Romero, F.J. (1998) “Experimental diabetic neuropathy: role of oxidative stress, mechanisms involved”, Biofactors 8, 41–43.
  • McGahon, B., Clements, M.P. and Lynch, M.A. (1997) “The ability of aged rats to sustain long-term potentiation is restored when the age-related decrease in membrane arachidonic acid concentration is reversed”, Neuroscience 81, 9–16.
  • McGahon, B.M., Martin, D.S.D., Horrobin, D.F. and Lynch, M.A. (1999a) “Age-related changes in LTP and antioxidant defences are reversed by an α-lipoic acid-enriched diet”, Neurobiol. Aging 20, 655–664.
  • McGahon, B.M., Murray, C.A., Horrobin, D.F. and Lynch, M.A. (1999b) “Age-related changes in oxidative mechanisms and LTP are reversed by dietary manipulation”, Neurobiol. Aging 20, 643–653.
  • McGahon, B.M., Martin, D.S.D., Horrobin, D.F. and Lynch, M.A. (1999c) “Age-related changes in synaptic function: analysis of the effect of dietary supplementation with ω-3 fatty acids”, Neuroscience 94, 305–314.
  • Murakami, K., Kondo, T., Kawase, M. and Chan, P.H. (1998) “The development of a new mouse model of global ischemia: focus on the relationships between ischemia duration, anesthesia, cerebral vasculature, and neuronal injury following global ischemia in mice”, Brain Res. 780, 304–310.
  • Murase, K., Hattori, A., Kohno, M. and Hayashi, K. (1993) “Stimulation of nerve growth factor synthesis/secretion in mouse astroglial cells by coenzymes”, Biochem. Mol. Biol. Int. 30, 615–621.
  • Murray, C. and Lynch, M.A. (1998a) “Evidence that increased hippocampal expression of the cytokine, IL-1β, is a common trigger for age and stress-induced impairments in long-term potentiation”, J. Neurosci. 18, 2974–2981.
  • Murray, C. and Lynch, M.A. (1998b) “Analysis of the mechanism by which supplementation with vitamin E and vitamin C restores ability of aged animals to sustain long-term potentiation in dentate gyrus”, J. Biol. Chem. 273, 12161–12168.
  • Murray, C.A., McGahon, B., McBennett, S. and Lynch, M.A. (1997) “Interleukin-1β inhibits glutamate release in hippocampal synaptosomes prepared from young adult but not aged rats”, Neurobiol. Aging 18, 343–348.
  • Nadler, V., Biegon, A., Beit-Yannai, E., Adamchik, J. and Shohami, E. (1995) “45Ca accumulation in rat brain after closed head injury; attenuation by the novel neuroprotective agent HU-211”, Brain Res. 685, 1–11.
  • Nagamatsu, M., Nickander, K.K., Schmelzer, J.D., Raya, A., Wittrock, D.A., Tritschler, H. and Low, P.A. (1995) “Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy”, Diabetes Care 18, 1160–1167.
  • Nickander, K.K., McPhee, B.R., Low, P.A. and Tritschler, H. (1996) “Alpha-lipoic acid: antioxidant potency against lipid peroxidation of neural tissue in vitro and implications for diabetic neuropathy”, Free Radical Biol. Med. 21, 631–639.
  • Obrosova, I.G., Fathallah, L. and Greene, D.A. (2000a) “Early changes in lipid peroxidation and antioxidative defence in diabetic rat retina: effect of DL-α-lipoic acid”, Eur. J. Pharmacol. 398, 139–146.
  • Obrosova, I.G., Van Huysen, C., Fathallah, L., Cao, X., Stevens, M.J. and Greene, D.A. (2000b) “Evaluation of alpha(1)-adrenoceptor antagonist on diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense”, FASEB J. 14, 1548–1558.
  • O'Donnell, E. and Lynch, M.A. (1998) “Age-related changes in handling ROS in cortical tissue: effect of dietary manipulation with vitamins E, C”, Neurobiol. Aging 19, 461–467.
  • O'Donnell, E., Vereker, E. and Lynch, M.A. (2000) “Age-related impairment in LTP is accompanied by enhanced activity of stress-activated protein kinases: analysis of underlying mechanisms”, Eur. J. Neurosci. 12, 345–352.
  • Ou, P., Tritschler, H.J. and Wolff, S.P. (1995) “Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant?”, Biochem. Pharmacol. 50, 123–126.
  • Packer, L., Tritschler, H.J. and Wessel, K. (1997) “Neuroprotection by the metabolic antioxidant α-lipoic acid”, Free Radical Biol. Med. 22, 359–378.
  • Panigrahi, M., Sadguna, Y., Shivakumar, B.R., Kolluri, S.V., Roy, S., Packer, L. and Ravindranath, V. (1996) “Alpha-lipoic acid protects against reperfusion injury following cerebral ischemia in rats”, Brain Res. 717, 184–188.
  • Rangan, G.K., Wang, Y., Tay, Y.C. and Harris, D.C. (1999) “Inhibition of NFκB activation with antioxidants is correlated with reduced cytokine transcription in PTC”, Am. J. Physiol. 277, F779–F789.
  • Rauhala, P, Sziraki, I. and Chiueh, C.C. (1996) “Peroxidation of brain lipids in vitro: nitric oxide versus hydroxyl radicals”, Free Radical Biol. Med. 21, 391–394.
  • Rehncrona, S., Folbergrova, J., Smith, D.S. and Siesjo, B.K. (1980) “Influence of complete and pronounced incomplete cerebral ischemia and subsequent recirculation on cortical concentrations of oxidized and reduced glutathione in the rat”, J. Neurochem. 34, 477–486.
  • Reiter, R.J. (1995) “Oxidative processes and antioxidative defense mechanisms in the aging brain”, FASEB J. 9, 526–533.
  • Reljanovic, M., Reichel, G., Rett, K., Lobisch, M., Schuette, K., Moller, W., Tritschler, H.J. and Mehnert, H. (1999) “Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN 11). Alpha lipoic acid in diabetic neuropathy”, Free Radical Res. 31, 171–179.
  • Rice-Evans, C. and Burdon, R. (1993) “Free radical-lipid peroxidations and their pathological consequences”, Prog. Lipid Res. 32, 71–110.
  • Rybak, L.P., Husain, K., Whitworth, C. and Somani, S.M. (1999a) “Dose dependent protection by lipoic acid against cisplatin-induced ototoxicity in rats: antioxidant defense system”, Toxicol. Sci. 47, 195–202.
  • Rybak, L.P., Whitworth, C. and Somani, S. (1999b) “Application of antioxidants and other agents to prevent cisplatin ototoxicity”, Laryngoscope 109, 1740–1744.
  • Sahoo, A. and Chainy, G.B. (1997) “Alterations in the activities of cerebral antioxidant enzymes of rat are related to aging”, Int. J. Dev. Neurosci. 15, 939–948.
  • Salazar, M.R. (2000) “Alpha lipoic acid: a novel treatment for depression”, Med. Hypotheses 55, 510–512.
  • Sandhya, P. and Varalakshmi, P. (1997) “Effect of lipoic acid administration on gentamicin induced lipid peroxidation in rats”, J. Appl. Toxicol. 17, 405–408.
  • Sastre, J., Pallardo, F.V., Garcia de la Asuncion, J. and Vina, J. (2000) “Mitochondria, oxidative stress and aging”, Free Radical Res. 32, 189–198.
  • Schleicher, E.D., Wagner, E. and Nerlich, A.G. (1997) “Increased accumulation of the glycoxidation product Nε-(carboxymethyl)lysine in human tissues in diabetes and aging”, J. Clin. Invest. 99, 457–468.
  • Scholich, H., Murphy, M.E. and Sies, H. (1989) “Antioxidant activity of dihydrolipoate against microsomal lipid peroxidation and its dependence on alpha-tocopherol”, Biochim. Biophys. Acta 1001, 256–261.
  • Scott, B.C., Aruoma, O.I., Evans, P.J., O'Neill, C., Van der Vliet, A., Cross, C.E., Tritschler, H. and HalliwelL, B. (1994) “Lipoic and dihydrolipoic acids as antioxidants. A critical evaluation”, Free Radical Res. 20, 119–133.
  • Seaton, T.A., Jenner, P. and Marsde, C.D. (1996) “Mitochondrial respiratory enzyme function and superoxide dismutase activity following brain glutathione depletion in the rat”, Biochem. Pharmacol. 52, 1657–1663.
  • Shigenaga, M.K., Hagen, T.M. and Ames, B.N. (1994) “Oxidative damage and mitochondrial decay in aging”, Proc. Natl Acad. Sci. 91, 10771–10778.
  • Shivakumar, B.R., Kolluri, S.V. and Ravindranath, V.J. (1995) “Glutathione and protein thiol homeostasis in brain during reperfusion after cerebral ischemia”, Pharmacol Exp. Ther. 274, 1167–1173.
  • Shohami, E., Beit-Yannai, E., Horowitz, M. and Kohen, R. (1997) “Oxidative stress in closed-head injury: brain antioxidant capacity as an indicator of functional outcome”, J. Cereb. Blood Flow Metab. 17, 1007–1019.
  • Smith, M.A., Sayre, L.M., Anderson, V.E., Harris, P.L., Beal, M.F., Kowall, N. and Perry, G. (1998a) “Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine”, J. Histochem. Cytochem. 46, 731–735.
  • Smith, R.G., Henry, Y.K., Mattson, M.P. and Appel, S.H. (1998b) “Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis”, Ann. Neurol. 44, 696–699.
  • Sofic, E., Reiderer, P., Heinsen, H., Beckmann, H., Reynolds, G.P., Hebenstreit, G. and Youdim, M. (1988) “Increased iron (III) and total iron content in post-mortem substantia nigra of parkinsonian brain”, J. Neural Transm. 74, 199–205.
  • Sohal, R.S. and Weindruch, R. (1996) “Oxidative stress, caloric restriction, and aging”, Science 273, 59–63.
  • Somani, S.M., Husain, K., Whitworth, C., Trammell, G.L., Malafa, M. and Rybak, L.P. (2000) “Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats: antioxidant defense system”, Pharmacol. Toxicol. 86, 234–241.
  • Spencer, J.P., Jenner, P, Daniel, S.E., Lees, A.J., Marsden, D.C. and Halliwell, B. (1998) “Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species”, J. Neurochem. 71, 2112–2122.
  • Stoll, S., Hartmann, H., Cohen, S.A. and Muller, W.E. (1993) “The potent free radical scavenger—lipoic acid improves memory in aged mice: putative relationship to NMDA receptor deficits”, Pharmacol. Biochem. Behav. 46, 799–805.
  • Stoll, S., Rostock, A., Bartsch, R., Korn, E., Meichelbock, A. and Muller, W.E. (1994) “The potent free radical scavenger alpha-lipoic acid improves cognition in rodents”, Ann. N. Y. Acad. Sci. 717, 122–128.
  • Suh, J.H., Shigeno, E.T., Morrow, J.D., Cox, B., Rocha, A.E., Frei, B. and Hagen, T.M. (2001) “Oxidative stress in the aging rat heart is reversed by dietary supplementation with (R)-(alpha)-lipoic acid”, FASEB J. 5, 700–706.
  • Sumathi, R., Baskaran, G. and Varalakshmi, P. (1996) “Relationship between glutathione and DL alpha-lipoic acid against cadmium-induced hepatotoxicity”, Jpn J. Med. Sci. Biol. 49, 39–48.
  • Svensson, L., Wu, C., Hulthe, P., Johannessen, K. and Engel, J.A. (1993) “Effect of ageing on extracellular ascorbate concentration in rat brain”, Brain Res. 609, 36–40.
  • Tirosh, O., Sen, C.K., Roy, S., Kobayashi, M.S. and Packer, L. (1999) “Neuroprotective effects of alpha-lipoic acid and its positively charged amide analogue”, Free Radical Biol. Med. 26, 1418–1426.
  • Toliver-Kinsky, T., Papaconstantinou, J. and Perez-Polo, J.R. (1997) “Age-associated alterations in hippocampal and basal forebrain nuclear factor kappa B activity”, J. Neurosci. Res. 48, 580–587.
  • Van der Goes, A., Brouwer, J., Hoekstra, K., Roos, D., van der Berg, T.K. and Dijkstra, C.D. (1999) “Reactive oxygen species are required for the phagocytosis of myelin by macrophages”, J. Neuroimmunol. 92, 67–75.
  • Vereker, E., O'Donnell, E. and Lynch, M.A. (2000a) “The inhibitory effect of interleukin-1β on LTP is coupled with increased activity of stress-activated protein kinases”, J. Neurosci. 20, 6811–6819.
  • Vereker, E., Campbell, V., Roche, E., McEntee, E. and Lynch, M.A. (2000b) “Lipopolysaccharide inhibits long-term potentiation in the rat dentate gyrus by activating caspase-1”, J. Biol. Chem. 275, 26252–26528.
  • Whiteman, M., Tritschler, H. and Halliwell, B. (1996) “Protection against peroxynitrite-dependent tyrosine nitration and α1-antiproteinase inactivation by oxidized and reduced lipoic acid”, FEBS Lett. 379, 74–76.
  • Zeevalk, G.D., Bernard, L.P. and Nicklas, W.J. (1998) “Role of oxidative stress and the glutathione system in loss of dopamine neurons due to impairment of energy metabolism”, J. Neurochem. 70, 1421–1430.
  • Zhang, J.-R., Andrus, P.K. and Hall, E.D. (1993) “Age-related regional changes in hydroxyl radical stress and antioxidants in gerbil brain”, J. Neurochem. 61, 1640–1647.
  • Ziegler, D., Hanefeld, M., Ruhnau, K.-J., Hasche, H., Lobish, M., Schutte, K., Kerum, G. and Malessa, R. (1999) “Treatment of symptomatic diabetic neuropathy with the antioxidant α-lipoic acid”, Diabetes Care 22, 1296–1301.
  • Zs.-Nagy, I. (1994) The Membrane Hypothesis of Aging (CRC Press Inc, Boca Raton, FL).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.